IBIO, INC. Cash and Restricted Cash
IBIO, INC. (IBIO) had Cash and Restricted Cash of $56.62 million as of 2026-06-30, per its 10-K filed 2026-08-28.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-28
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $56.62M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $47.86M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $28.90M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $28.34M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $56.62M 10-K · filed 2026-08-28 | |
| 2026-03-31 | $47.86M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $28.90M 10-Q · filed 2026-02-10 | |
| 2025-09-30 | $28.34M 10-Q/A · filed 2025-11-17 | |
| 2025-06-30 | $8.79M 10-K · filed 2026-08-28 | |
| 2025-03-31 | $5.18M 10-Q · filed 2026-05-12 | |
| 2024-12-31 | $7.24M 10-Q · filed 2026-02-10 | |
| 2024-09-30 | $11.26M 10-Q/A · filed 2025-11-17 | |
| 2024-06-30 | $14.43M 10-K · filed 2026-08-28 | |
| 2024-03-31 | $6.43M 10-Q · filed 2025-05-02 | |
| 2023-12-31 | $4.06M 10-Q · filed 2025-02-10 | |
| 2023-09-30 | $4.76M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $7.58M 10-K · filed 2025-09-05 | |
| 2023-03-31 | $9.78M 10-Q · filed 2024-05-13 | $9.81M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $3.95M 10-Q · filed 2024-02-09 | |
| 2022-09-30 | $15.88M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $28.67M 10-K/A · filed 2024-09-24 | |
| 2022-03-31 | $39.71M 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $45.15M 10-Q/A · filed 2023-05-19 | |
| 2021-09-30 | $62.82M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $77.40M 10-K · filed 2023-09-27 | |
| 2021-03-31 | $84.63M 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $91.25M 10-Q · filed 2022-02-14 | |
| 2020-06-30 | $55.11M 10-K · filed 2022-10-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |